IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MITOLA, STEFANIA MARIA FILOMENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.012
NA - Nord America 7.654
AS - Asia 2.439
OC - Oceania 18
SA - Sud America 14
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 18.155
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.628
PL - Polonia 5.044
CN - Cina 1.083
UA - Ucraina 803
IT - Italia 748
DE - Germania 459
SG - Singapore 445
HK - Hong Kong 281
VN - Vietnam 247
FI - Finlandia 244
GB - Regno Unito 202
IE - Irlanda 148
TR - Turchia 147
IN - India 83
FR - Francia 80
ID - Indonesia 78
ES - Italia 53
BE - Belgio 48
SE - Svezia 44
CZ - Repubblica Ceca 41
NL - Olanda 19
RU - Federazione Russa 17
CA - Canada 16
AU - Australia 14
JP - Giappone 14
CH - Svizzera 11
IR - Iran 11
GR - Grecia 9
EE - Estonia 7
EU - Europa 7
NO - Norvegia 7
AR - Argentina 6
MA - Marocco 6
CL - Cile 5
KR - Corea 5
PH - Filippine 5
AZ - Azerbaigian 4
BD - Bangladesh 4
BG - Bulgaria 4
IL - Israele 4
KG - Kirghizistan 4
MX - Messico 4
NZ - Nuova Zelanda 4
RO - Romania 4
AL - Albania 3
DK - Danimarca 3
HU - Ungheria 3
MY - Malesia 3
PA - Panama 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
PT - Portogallo 2
ZA - Sudafrica 2
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
OM - Oman 1
PE - Perù 1
TW - Taiwan 1
Totale 18.155
Salva come PNG Salva come JPEG
Città #
Warsaw 5.044
Fairfield 1.086
Woodbridge 719
Houston 672
Jacksonville 609
Ashburn 582
Ann Arbor 495
Seattle 436
Cambridge 419
Brescia 415
Chandler 384
Singapore 366
Wilmington 361
Princeton 279
Hong Kong 278
Dong Ket 241
Dearborn 197
Nanjing 197
Beijing 162
Helsinki 146
Dublin 144
New York 142
Istanbul 131
Milan 78
Jakarta 77
Nanchang 76
Jinan 70
Des Moines 69
Shanghai 67
Shenyang 64
Hebei 59
Changsha 55
Madrid 50
Brussels 46
San Diego 46
Jiaxing 35
Phoenix 35
Boardman 34
Munich 34
Los Angeles 33
Tianjin 30
Hangzhou 29
London 29
Haikou 27
Kunming 26
Zhengzhou 25
Lancaster 23
Ningbo 22
Washington 22
Brno 20
Guangzhou 20
San Mateo 19
San Francisco 17
Olomouc 16
Verona 16
Taizhou 15
Augusta 14
Hefei 14
Rome 14
Lanzhou 13
Kilburn 12
Leawood 12
Monmouth Junction 12
Orange 12
Pavia 12
Amsterdam 11
Taiyuan 11
Chicago 10
Fara Gera d'Adda 10
Toronto 10
Redwood City 9
Santa Clara 9
Tokyo 9
Fuzhou 8
Kocaeli 8
Ardabil 7
Lappeenranta 7
Melbourne 7
Norwalk 7
Pune 7
Tallinn 7
Chiswick 6
Naples 6
Padova 6
Romola 6
San Giovanni Rotondo 6
Basel 5
Buenos Aires 5
Changchun 5
Linköping 5
Prescot 5
Sant'angelo Lodigiano 5
Baku 4
Bishkek 4
Bologna 4
Calvisano 4
Cazzago San Martino 4
Dhaka 4
Gunzenhausen 4
Mumbai 4
Totale 15.133
Salva come PNG Salva come JPEG
Nome #
Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. 361
Annexin 2A sustains glioblastoma cell dissemination and proliferation. 317
Multi-physics interactions drive VEGFR2 relocation on endothelial cells. 257
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 250
Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis 242
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 238
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 234
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 233
Claudin3 is localized outside the tight junctions in human carcinomas 233
Tumor angiogenesis revisited: Regulators and clinical implications 231
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 230
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 229
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 226
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 225
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 224
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 222
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 217
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 216
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 216
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 216
A study on the VEGFR2-ligand multi-physics interactions in Angiogenesis. 216
Cortical Structure Alterations and Social Behavior Impairment in p50-Deficient Mice 215
Regulation of dendritic cell migration and adaptive immune response by leukotriene b4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function 211
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 210
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 208
Integrins: A flexible platform for endothelial vascular tyrosine kinase receptors. 206
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 203
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 203
Involvement of chemokine receptor4/ cell-derived factor 1 system during osteosarcoma tumor progression 202
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 202
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells. 200
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 199
IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. 199
Interactions between endothelial cells and HIV-1. 194
Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. 193
Nitric oxide modulates the angiogenic phenotype of middle-T transformed endothelial cells. 191
Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1. 190
Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. 188
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 187
Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro. 186
Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells. 182
Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. 178
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 178
Preliminary observations on scleral ossicles in performing functionalized 3D vascularized scaffolds for “critical-size” bone defect healing 172
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 169
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 167
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 157
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation 157
Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivative.Effect on the motility of vascular endothelial cells. 151
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 149
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 147
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 144
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 144
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 142
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 141
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 139
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 137
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 131
Silencing of pantothenate kinase 2 reduces endothelial cell angiogenesis 130
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 129
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 124
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 120
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 118
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 117
Biosafe inertization of municipal solid waste incinerator residues by COSMOS technology. 117
Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process 117
A Model of Integrin and VEGF Receptors Recruitment on Endothelial Cells 117
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 117
Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. 116
IL-12 regulates an endothelial cell-lymphocyte network: effect on metalloproteinase-9 production. 116
CCL16 activates an angiogenic program in vascular endothelial cells 111
Design, Synthesis, in Vitro and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylamino Benzofuran Derivatives Targeting the Colchicine Site on Tubulin 110
The Ferritin-Heavy-Polypeptide-Like-17 (FTHL17) gene encodes a ferritin with low stability and no ferroxidase activity and with a partial nuclear localization 106
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 105
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 104
Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels 102
Gremlin as a novel pro-angiogenic VEGFR2 agonist: production of a biologically active recombinant form in S2 Drosophila cells 100
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 100
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 98
Insights on the receptor dynamics during the spreading of endothelial cells 98
Dendritic cell-endothelial cell cross-talk in angiogenesis. 96
Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. 96
Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production. 95
Evaluation of Paracellular Permeability in VEGFR2 Mutants Patient-Derived Organoid 95
Fibroblast growth factor-2 in angiogenesis 94
Vascular disrupting activity of combretastatin analogues 94
Inhibition of vascular endothelial growth factor receptor 2 - mediated endothelial cell activation by Axl tyrosine kinase receptor. 90
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 88
Role of inflammation in FGF2-driven angiogenesis 87
Co-designed experiments and multi-physics modeling of the VEGFR-2 relocation on endothelial cells. 87
Simulation of VEGF receptor recruitment on ECs membrane 86
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 84
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 79
Role of VEGFR2 co-receptors in the modulation of the pro-angiogenic activity of gremlin. 78
Role of VEGFs in metabolic disorders 78
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 77
Nicotine produces structural plasticity of mesencephalic dopaminergic neurons via activation of Akt-mTor pathway 76
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 76
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 76
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 75
Totale 15.784
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.182
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.731 0 0 0 0 427 640 540 562 435 547 309 271
2020/20213.486 157 322 239 410 227 343 190 342 366 302 274 314
2021/20221.291 81 244 27 28 37 69 74 72 67 176 103 313
2022/20231.191 198 78 61 69 90 276 22 103 166 15 42 71
2023/20241.607 85 71 154 124 91 243 60 101 295 119 40 224
2024/2025950 69 25 38 485 333 0 0 0 0 0 0 0
Totale 18.501